At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Feb 26, 2026 at 19:00 ET
A recent insider trading cluster at United Therapeutics shows CEO Martine Rothblatt exercising options for nearly $2.8M in shares, while two other insiders conducted small open-market sales totaling $127K. The majority of activity consists of derivative exercises, not open-market selling.
- CEO Martine Rothblatt exercised derivatives for 19,000 shares valued at $2,774,570 across two transactions on March 2 and 3, 2026.
- Two open-market sales occurred: Malcolm Jan sold $25,460 worth of shares and Judy Olian sold $101,910 worth.
- Total open-market selling in the cluster: $127,370, consistent with recent 30-day insider activity.
- Derivative exercises (M-coded transactions) are non-cash events and do not represent shares sold into the market.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access